Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

    Virtual Booth

    Contact Supplier

    Menu

    Sovateltide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 302,840Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmazz Begins Phase 3 Trial of Sovateltide for Ischemic Stroke
    Pharmazz Begins Phase 3 Trial of Sovateltide for Ischemic Stroke

    29 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/29/3123098/0/en/Pharmazz-Inc-Announces-Enrollment-of-First-Patient-in-Phase-3-Clinical-Trial-of-Sovateltide-for-Treating-Patients-with-Cerebral-Ischemic-Stroke.html

    GLOBENEWSWIRE
    29 Jul 2025
    Share Share
    Pharmazz Inc. gets $25M investment from Sun Pharma
    Pharmazz Inc. gets $25M investment from Sun Pharma

    11 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/11/3097415/0/en/Pharmazz-Inc-Secures-25-Million-Strategic-Equity-Investment-from-Sun-Pharmaceutical-Industries-Ltd.html

    GLOBENEWSWIRE
    11 Jun 2025
    Share Share
    Sun Pharma To Invest Up To $15M In Pharmazz
    Sun Pharma To Invest Up To $15M In Pharmazz

    21 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/21/2933391/0/en/Pharmazz-Inc-and-Sun-Pharma-entered-into-an-agreement-under-which-Sun-Pharma-will-invest-up-to-15-Million-in-Pharmazz-Inc.html

    GLOBENEWSWIRE
    21 Aug 2024
    Share Share
    A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide
    A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide

    02 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/02/2752648/0/en/A-Special-Protocol-Assessment-Agreement-Reached-with-the-U-S-Food-and-Drug-Administration-for-Phase-3-clinical-trial-of-Sovateltide-for-the-treatment-of-acute-cerebral-ischemic-str.html

    GLOBENEWSWIRE
    02 Oct 2023
    Share Share
    Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide
    Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide

    13 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmazz-inc-announces-us-fda-clearance-for-a-phase-iii-clinical-trial-of-sovateltide-pmz-1620-in-acute-cerebral-ischemic-stroke-patients-301744465.html

    PR NEWSWIRE
    13 Feb 2023
    Share Share
    Clinical PIII Trial Results Demonstrating Sovateltide's Efficacy
    Clinical PIII Trial Results Demonstrating Sovateltide's Efficacy

    10 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clinical-phase-iii-trial-results-demonstrating-sovateltides-efficacy-to-treat-acute-cerebral-ischemic-stroke-presented-at-the-international-stroke-conference-2023-301741886.html

    PR NEWSWIRE
    10 Feb 2023
    Share Share